-
公开(公告)号:US3869444A
公开(公告)日:1975-03-04
申请号:US29643172
申请日:1972-10-10
Applicant: ABBOTT LAB
Inventor: FREIBERG LESLIE ALAN
IPC: A01N43/22 , C07C63/70 , C07D295/192 , C07H17/08 , C07C47/18
CPC classification number: C07D295/192 , C07C63/70 , C07H17/08
Abstract: Covers stable oxime esters of erythromycin oximes, which are active antibiotic agents.
Abstract translation: 涵盖稳定的红霉素肟的肟酯,它们是活性抗生素。
-
2.
公开(公告)号:US3681325A
公开(公告)日:1972-08-01
申请号:US3681325D
申请日:1970-09-30
Applicant: ABBOTT LAB
Inventor: FREIBERG LESLIE ALAN
CPC classification number: C07H17/08
Abstract: NEW DERIVATIVES OF ERTHROMYCIN A AND B, HAVING ANTIMICROBIAL ACTIVITY OF THE FORMULA
2-(ERY-O-),3-HO,4-(CH3-N(-Z)-),6-CH3-PERHYDROPYRAN
WHEREIN Z IS BENZYL; HALO, NITRO, AMINO, LOWERALKYL, LOWERALKOXY, CARBOXYBENZYL, HALOLOWERALKYL, DILOWERALKYLAMINOMETHYL, CARBOXY, LOWERALKOXYMETHYL, CYANO AND HYDROCARBYLENE SUBSTITUTED BENZYL; ALLYL, LOWERALKYL AND PHENYLSUBSTITUTED B AND Y ALLYL, E.G., CROTYL; CYANO; AND CYANOLOWERALKYL; AND ERY IS THE CLADINOSE AND ERYTHRONOLIDE MOIETIES OF ERYTHROMYCIN.-
公开(公告)号:DE2855077A1
公开(公告)日:1979-07-05
申请号:DE2855077
申请日:1978-12-20
Applicant: ABBOTT LAB
IPC: C07H15/224 , C07H15/22 , A61K31/35
-
公开(公告)号:GB2118180A
公开(公告)日:1983-10-26
申请号:GB8308762
申请日:1983-03-30
Applicant: ABBOTT LAB
Inventor: TADANIER JOHN SOLOMAN , HALLAS ROBERT , FREIBERG LESLIE ALAN , BACINO DAVID JAMES
IPC: A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/7036 , A61P31/04 , C07H15/224 , C07H15/22 , A61K31/71
Abstract: Disclosed herein are fortimicin derivatives represented by the formula: wherein R is hydrogen, loweralkyl, aminoloweralkyl, diaminoloweralkyl, N-loweralkylaminoloweralkyl, N,N-diloweralkylaminoloweralkyl, hydroxyloweralkyl, aminohydroxyloweralkyl, N-loweralkylaminohydroxyloweralkyl, N,N-diloweralkylaminohydroxyloweralkyl, loweracyl, aminoloweracyl, diaminoloweracyl, hydroxyloweracyl, N-loweralkylaminoloweracyl, N,N-diloweralkylaminoloweracyl, or aminohydroxyloweracyl, and the pharmaceutically acceptable salts thereof. Also disclosed are intermediates useful in the preparation of these compounds and compositions of these compounds together with a pharmaceutically acceptable carrier and/or diluent.
-
公开(公告)号:AU3385571A
公开(公告)日:1973-03-29
申请号:AU3385571
申请日:1971-09-23
Applicant: ABBOTT LAB
Inventor: FREIBERG LESLIE ALAN
Abstract: The 3-dimethyl amino substituent of the desosamine and mycaminose moieties of macrolide antibiotics are mono- and didemethylated by reaction with halogen, preferably iodine, in the presence of base at a controlled pH. The resulting compounds have antibiotic activity, and furthermore are useful as intermediates for alkylation and the like.
-
公开(公告)号:IT1164161B
公开(公告)日:1987-04-08
申请号:IT2050983
申请日:1983-04-08
Applicant: ABBOTT LAB
Inventor: TADANIER JOHN SOLOMAN , HALLAS ROBERT , FREIBERG LESLIE ALAN , BACINO DAVID JAMES
IPC: A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/7036 , A61P31/04 , C07H15/224 , A61K
Abstract: Disclosed herein are fortimicin derivatives represented by the formula: wherein R is hydrogen, loweralkyl, aminoloweralkyl, diaminoloweralkyl, N-loweralkylaminoloweralkyl, N,N-diloweralkylaminoloweralkyl, hydroxyloweralkyl, aminohydroxyloweralkyl, N-loweralkylaminohydroxyloweralkyl, N,N-diloweralkylaminohydroxyloweralkyl, loweracyl, aminoloweracyl, diaminoloweracyl, hydroxyloweracyl, N-loweralkylaminoloweracyl, N,N-diloweralkylaminoloweracyl, or aminohydroxyloweracyl, and the pharmaceutically acceptable salts thereof. Also disclosed are intermediates useful in the preparation of these compounds and compositions of these compounds together with a pharmaceutically acceptable carrier and/or diluent.
-
公开(公告)号:GR73848B
公开(公告)日:1984-05-07
申请号:GR810164112
申请日:1981-02-12
Applicant: ABBOTT LAB
Inventor: BODOR NICHOLAS S , FREIBERG LESLIE ALAN
IPC: A61K31/70 , A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08
Abstract: High water-soluble erythromycin A derivatives wherein the desosamine moiety is quaternized with an acyloxy-, benzoyloxy- or alkoxycarbonyl-(or carboxy)-acylmethyl iodide, bromine or chloride and esterified in the 2-position with loweralkyl or -(CH2)nCO2R sec , wherein R sec is H, loweralkyl or substituted loweralkyl and n is an integer from 1-5. These new esters readily convert to erythromycin A upon administration to warm-blooded animals.
-
公开(公告)号:PH15478A
公开(公告)日:1983-01-27
申请号:PH21877
申请日:1978-12-04
Applicant: ABBOTT LAB
IPC: C07H15/224 , C07G3/00 , A61K35/00 , C07G11/00
-
公开(公告)号:AU521715B2
公开(公告)日:1982-04-29
申请号:AU4108578
申请日:1978-10-26
Applicant: ABBOTT LAB
IPC: C07H15/224 , A61K31/71 , C07H15/22
-
公开(公告)号:AU4108578A
公开(公告)日:1980-05-01
申请号:AU4108578
申请日:1978-10-26
Applicant: ABBOTT LAB
IPC: C07H15/224 , C07H15/22 , A61K31/71
-
-
-
-
-
-
-
-
-